Steris (STE) Other Non-Current Assets (2018 - 2026)
Steris' (STE) quarterly Other Non-Current Assets came in at $211.4 million in Q1 2026, up 154.7% year-on-year from $83.0 million in Q1 2025, and up 125.85% quarter-over-quarter from $93.6 million in Q4 2025.
Steris (STE) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Steris' Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $211.4 million for Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 154.7% year-over-year to $211.4 million in Q1 2026; TTM through Mar 2026 was $211.4 million, a 154.7% increase from a year earlier, with the FY2026 full-year figure at $211.4 million, up 154.7% from the prior year.
- Other Non-Current Assets grew to $211.4 million in Q1 2026 per STE's latest filing, from $93.6 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $977.3 million in Q1 2023 and bottomed at $60.3 million in Q3 2024.
- The 5-year median for Other Non-Current Assets is $80.2 million (2022), against an average of $187.1 million.
- Across the five-year window, Other Non-Current Assets soared 1283.02% in 2023 and tumbled 89.69% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $80.4 million in 2022, then declined by 3.76% to $77.3 million in 2023, then decreased by 22.07% to $60.3 million in 2024, then soared by 55.31% to $93.6 million in 2025, then soared by 125.85% to $211.4 million in 2026.
- Per Business Quant, the three latest STE Other Non-Current Assets figures stand at $211.4 million (Q1 2026), $93.6 million (Q4 2025), and $87.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 211.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 211.40 Mn |
| Dec 31, 2025 | 93.60 Mn |
| Sep 30, 2025 | 87.90 Mn |
| Jun 30, 2025 | 88.60 Mn |
| Mar 31, 2025 | 83.00 Mn |
| Sep 30, 2024 | 60.27 Mn |
| Jun 30, 2024 | 63.13 Mn |
| Mar 31, 2024 | 804.90 Mn |
| Dec 31, 2023 | 77.34 Mn |
| Sep 30, 2023 | 72.63 Mn |
| Jun 30, 2023 | 80.04 Mn |
| Mar 31, 2023 | 977.26 Mn |
| Dec 31, 2022 | 80.36 Mn |
| Sep 30, 2022 | 72.23 Mn |
| Jun 30, 2022 | 70.16 Mn |
| Mar 31, 2022 | 70.66 Mn |
| Dec 31, 2021 | 55.90 Mn |
| Sep 30, 2021 | 50.12 Mn |
| Jun 30, 2021 | 51.45 Mn |
| Mar 31, 2021 | 52.72 Mn |